Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
Jun 14, 2013
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Jun 7, 2013
PDF 18.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 24, 2013
PDF 10.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
May 7, 2013
PDF 16.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
May 2, 2013
PDF 23.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
Apr 26, 2013
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
Apr 5, 2013
PDF 11.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Eisai's Submission of BELVIQ® (lorcaserin HCl) Marketing Authorization Application in Mexico
Apr 1, 2013
PDF 17.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
Mar 4, 2013
PDF 25.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Feb 27, 2013
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
Feb 25, 2013
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 6, 2013
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
Jan 2, 2013
PDF 10.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
Dec 6, 2012
PDF 9.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Nov 28, 2012
PDF 12.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference
Nov 21, 2012
PDF 10.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Nov 8, 2012
PDF 10.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
Nov 6, 2012
PDF 24.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Establishes BELVIQ® (lorcaserin HCl) Marketing and Supply Agreement with Ildong Pharmaceutical for South Korea
Nov 6, 2012
PDF 14.4 KB Add to Briefcase
Showing 41-60 of 455 Page: 1 2 3 4 5 6 7 ... 23  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase